Intravitreal Dexamethasone Implant for Patients With Central Retinal Vein Occlusion: Four-Year Outcomes in a Real-World Study
In this series of patients with macular edema secondary to CRVO, a demonstrable improvement in BCVA was recorded along with CST decrease at a long-term follow-up of four years. Only naïve treatment with DEX implant negatively correlated with visual acuity outcomes, but it was not confirmed at the multivariate analysis. Therefore, there was no evidence to support a predictive relationship between demographic and baseline anatomical factors and final BCVA and CST.
Authors
- Asimina Mataftsi (ORCID: https://orcid.org/0000-0002-4238-022X)
- Irini Chatziralli (ORCID: https://orcid.org/0000-0001-8523-1024)
- PANAGIOTIS G. THEODOSSIADIS (ORCID: https://orcid.org/0000-0002-1460-0838)
- Anastasia Gkiala
- Chrysa Agapitou (ORCID: https://orcid.org/0009-0008-2778-9773)
- Tatiana Tziola (ORCID: https://orcid.org/0000-0003-2742-1502)
- Anna‐Bettina Haidich (ORCID: https://orcid.org/0000-0001-5100-8799)
- Eleni Dimitriou
Institutions
- Aristotle University of Thessaloniki (GR)
Publication Details
- Journal
- Cureus
- Published
- 2025-03-11
- DOI
- https://doi.org/10.7759/cureus.80391
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00